Amoy Diagnostics Bilanço Sağlığı
Finansal Sağlık kriter kontrolleri 5/6
Amoy Diagnostics has a total shareholder equity of CN¥1.8B and total debt of CN¥52.9M, which brings its debt-to-equity ratio to 2.9%. Its total assets and total liabilities are CN¥2.0B and CN¥227.1M respectively. Amoy Diagnostics's EBIT is CN¥326.0M making its interest coverage ratio -13.4. It has cash and short-term investments of CN¥1.1B.
Anahtar bilgiler
2.9%
Borç/özkaynak oranı
CN¥52.95m
Borç
Faiz karşılama oranı | -13.4x |
Nakit | CN¥1.09b |
Eşitlik | CN¥1.81b |
Toplam yükümlülükler | CN¥227.13m |
Toplam varlıklar | CN¥2.04b |
Son finansal sağlık güncellemeleri
Recent updates
Amoy Diagnostics Co., Ltd.'s (SZSE:300685) Earnings Haven't Escaped The Attention Of Investors
Sep 18Are Investors Undervaluing Amoy Diagnostics Co., Ltd. (SZSE:300685) By 23%?
Aug 23Amoy Diagnostics' (SZSE:300685) Upcoming Dividend Will Be Larger Than Last Year's
May 27Earnings Report: Amoy Diagnostics Co., Ltd. Missed Revenue Estimates By 6.1%
Apr 24Amoy Diagnostics (SZSE:300685) Could Easily Take On More Debt
Apr 18What Amoy Diagnostics Co., Ltd.'s (SZSE:300685) 33% Share Price Gain Is Not Telling You
Mar 02Is Amoy Diagnostics Co., Ltd. (SZSE:300685) Worth CN¥22.0 Based On Its Intrinsic Value?
Mar 01Finansal Durum Analizi
Kısa Vadeli Yükümlülükler: 300685's short term assets (CN¥1.7B) exceed its short term liabilities (CN¥216.3M).
Uzun Vadeli Yükümlülükler: 300685's short term assets (CN¥1.7B) exceed its long term liabilities (CN¥10.8M).
Borç-Özkaynak Tarihçesi ve Analizi
Borç Seviyesi: 300685 has more cash than its total debt.
Borcun Azaltılması: 300685's debt to equity ratio has increased from 0% to 2.9% over the past 5 years.
Borç Kapsamı: 300685's debt is well covered by operating cash flow (611.4%).
Faiz Kapsamı: 300685 earns more interest than it pays, so coverage of interest payments is not a concern.